Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
20 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
THERABEL IMMO from Vorst, company number BE0428944292, closed financial year 2025 with a result of € -881,764 after tax. For that financial year THERABEL IMMO recorded revenue of € 396,306 and equity of € 15.6 million. Compared with financial year 2024, the result moved from € -647,429 to € -881,764. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 10, 2026.
€ 15.6 million
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -881,764
▼ 36 % more loss than in 2024
Profit after tax over the fiscal year.
€ 72,969
▲ 24% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -2.9 million.
People and assets in 2025
3
Average over the fiscal year, from the social balance sheet.
€ 174,685
▲ 20% vs 2024
€ 58,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 2.6 million
▲ 73% vs 2024
Loans from banks and other lenders, long and short.
€ 79,758
▲ 105% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 67 days on average.
€ 12,577
▼ 41% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 394,503 | € 355,030 | € 454,494 | € 396,306 | ▼ 13% |
| Profit after taxes | € -582,598 | € -813,189 | € -647,429 | € -881,764 | ▼ € 234,335 |
| Equity | € 17,935,018 | € 17,121,829 | € 16,474,400 | € 15,592,636 | ▼ 5% |
| Total debts | € 75,468 | € 1,478,661 | € 1,576,599 | € 2,797,394 | ▲ 77% |
| Cash | € 239,097 | € 103,653 | € 58,882 | € 72,969 | ▲ 24% |
| Land & buildings | € 16,276,318 | € 16,140,875 | € 15,926,612 | € 16,470,436 | ▲ 3% |
| Retained profit | € -607,433 | € -1,420,622 | € -2,068,051 | € -2,949,815 | ▼ € 881,764 |
| Bank debt | € 0 | € 1,300,000 | € 1,500,000 | € 2,600,000 | ▲ 73% |
| Balance sheet total | € 18,010,486 | € 18,600,490 | € 18,050,999 | € 18,390,030 | ▲ 2% |
| Employees (FTE) | 3 | 3 | 3 | 3 |
Key figures of THERABEL IMMO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to THERABEL IMMO?
What happened at THERABEL IMMO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Healthcare Expert Consulting stepped down as director. NBB
- BAWIP Consultants SRL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 881,764. Source: NBB ↗
- Healthcare Expert Consulting became a director. NBB
- BAWIP Consultants SRL became a director. NBB
- New establishment in Vorst. KBO
- Start of the company according to the CBE. KBO
In short
From € 582,598 loss in 2022 to € 881,764 loss in 2025.
Pays suppliers within 67 days on average.
A new publication or filing at THERABEL IMMO? We notify you, reason included.
Follow THERABEL IMMODatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Managing director · represented by Laurent KIRSCH
Also active at: S.A Therabel-Pharma N.V., THERABEL INTERNATIONAL SERVICES
since 2025 · until 2027
Director · represented by Philippe Burtonboy
Also active at: S.A Therabel-Pharma N.V., THERABEL INTERNATIONAL SERVICES
since 2025 · until 2027
Establishments
Establishment units
Physical locations of this company
Humaniteitslaan 292
1190 Vorst
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
All companies at this address →BIOCODEX Benelux
€ 20 million revenue · 2025
ATAG Heating Belgium
€ 11.5 million revenue · 2025
S.A Therabel-Pharma N.V. same network
€ 15.7 million revenue · 2025
CARLOS INTERNATIONAL
ALERT MANAGEMENT CONSULTANTS
€ 78,724 gross margin · 2025
+15 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0428.944.292
- VAT number
- BE 0428.944.292
- Registered office
- Humaniteitslaan 292, 1190 Vorst
- Names & denominations
- THERABEL IMMO
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 May 1986
- Peppol
- Active · Active since 23 Jan 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Handel in eigen onroerend goed
Vervaardiging van geneesmiddelen
Ontwikkeling van residentiële bouwprojecten